Guest View
User: Pass: | become a member
Archive for the ‘Benzinga’ Category

Benzinga’s M&A Chatter for Tuesday June 24, 2014

Courtesy of Benzinga.

The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday June 24, 2014:

Endo International to Acquire DAVA Pharma for $575M Cash and Up to $25M in Milestone Payments

The Deal:
Endo International (NASDAQ: ENDP) announced Tuesday that it has agreed to acquire privately-held DAVA Pharmaceuticals for $575 million in cash, plus additional cash consideration of up to $25 million contingent on achieving certain sales milestones. The deal is expected to close in H2 of 2014.

Endo International closed Tuesday at $70.26, a gain of more than 2%.

ARC Group Announces Acquisition of Kecy Corporation For $26M

The Deal:
ARC Group Worldwide (ARCW) announced Tuesday, it has agreed to acquire precision metal stamping company, Kecy Corporation for $26 million in cash. The closing of the Kecy Acquisition is expected to occur on June 25, 2014.

ARC Group closed Tuesday at $17.54, a gain of almost 2%.

IMS Health to Acquire Cegedim’s Information Solutions and CRM Businesses for $520M in Cash

The Deal:
IMS Health (NYSE: IMS) announced Tuesday, its intention to acquire certain Cegedim information solutions and Customer Relationship Management businesses for approximately $520 million in cash. The deal is expected to close in early 2015.

IMS Health closed Tuesday at $23.21, and traded as high as $24.76 after-hours.

Valeant CEO Says Major Allergan Shareholders Support $53B Proposal

The CEO Comments:
Shares of Allergan (NYSE: AGN) spiked higher Tuesday, on comments by Valeant (NYSE: VRX) CEO Pearson, that major Allergan shareholders supported the $53 billion bid by Valeant, and the company would soon have enough support for an Allergan shareholder vote on the hostile takeover attempt. Pearson also said Valeant was pursuing no other large deals, while they are working on completing the Allergan deal.

25% of Valeant shareholders are needed to convene the vote. Activist investor Bill Ackman holds almost a 10% stake in Allergan.

Allergan closed Tuesday at $165.35, a gain of $0.53. Valeant closed at $120.52, a loss of $0.69.

Report Aetna Considers Sale of Coventry Health Care Assets Valued at $1.5B

The Rumor:
Aetna (NYSE: …
continue reading





iPad Slump Leads To A Difficult Q3 For Apple

Courtesy of Benzinga.

Related AAPL
Verizon Tops Earnings, Revenues; Profits Up Double Digits
Earnings Season Boosts Confidence; S&P Trades At Record Highs
Apple Profit Up 12% on Strong iPhone Sales (Fox Business)

Apple (NASDAQ: AAPL) appears to have let Wall Street down.

iPhone and Mac sales led the way with nine and 13 percent growth year over year, respectively. On the other hand, iPad revenue slumped by eight percent compared to the same period last year. In terms of units, Apple sold 13 percent more iPhones, 18 percent more Macs and nine percent less iPads.

Globally, China led the way with a massive 28 percent year-over-year sales increase. On the other hand, sales in the Americas improved by just one percent.

Related Link: Barclays: Chipotle 'Remains An Anomaly'

As a whole, revenue missed analyst expectations by 1.5 percent at $37.4 billion versus $38 billion. This is a six percent year-over-year increase.

The silver lining of the report was that Apple was able to show its scale. Earnings increased by 19.6 percent on a six percent revenue boost. This figure is four percent better than analysts expected. Gross margins increased to 39.4 percent from 36.9 percent.

Arguably the most bearish aspect of the report is disappointing sales guidance. Fourth quarter sales are expected in the range of $37 billion to $40 billion, compared to the analysts estimate of $40.6 billion. Gross margins for the quarter are expected between 37 and 38 percent.

CEO Tim Cook commented, “Our record June quarter revenue was fueled by strong sales of iPhone and Mac and the continued growth of revenue from the Apple ecosystem, driving our highest EPS growth rate in seven quarters. We are incredibly excited about the upcoming releases of iOS 8 and OS X Yosemite, as well as other new products and services that we can’t wait to introduce.”

Shares of Apple were last trading after-hours 0.05 percent lower at $94.67.

Posted-In: iPad iPhone MacEarnings News Guidance Hot After-Hours Center





Warren Resources Enters Marcellus with Citrus Asset Buy – Analyst Blog

Courtesy of Benzinga.

Independent energy company, Warren Resources, Inc. (NASDAQ: WRES) announced that it has acquired certain assets in Pennsylvania’s Marcellus Shale from Colorado-based oil and natural gas producer, Citrus Energy Corporation and two other parties that owned working interest in the region. The transaction, which marks Warren Resources’ entry into the prolific natural gas basin, was for a purchase price of $352.5 million.

Following this announcement, shares of Warren Resources gained around 2.6% to close at $6.30. Shares also touched an intraday high of $6.70 that marked a new 52-week high for the stock.

The company mentioned that it will issue $40 million in shares at $6.00 per share as part of the transaction cost. The remaining consideration will be funded through debt financing. In view of this deal, Warren Resources’ senior secured credit facility has been increased to $750 million from $300 million and its borrowing base expanded to $225 million from $175 million. The transaction has an effective date of Jul 1 and is anticipated to close in early August.

The company added that the acquisition adds lucrative assets to its existing portfolio. The sold properties yielded about 82 million net cubic feet of natural gas per day last month. As of Jul 1, the estimated proved reserves totaled about 208.3 billion cubic feet, of which 55% is anticipated to be proved developed reserve.

Warren Resources will be the operator of the assets. The acquired properties are expected to complement the company’s existing California oil and Wyoming natural gas assets. The said properties are expected to be highly accretive and are anticipated to increase the company’s net production by over 200% to 118 million cubic feet equivalent per day (Mmcfe/d) from the existing level of 36 Mmcfe/d. The deal would also increase the company’s proved reserves to around 410.8 billion cubic feet equivalent (Bcfe) from the current level of 202.5 Bcfe.
 
The company stated that the acquisition has brought to its portfolio some of the top performing wells in the Marcellus region that generate significant cash, which should be enough to finance future drilling prospects in the area.

Warren Resources currently has a Zacks Rank #3 (Hold). Meanwhile, one can consider some…
continue reading





Rumor: ZF Bid For TRW Automotive Sweetened To $13 Billion

Courtesy of Benzinga.

Related TRW
Earnings Season Boosts Confidence; S&P Trades At Record Highs
Markets Sell-Off After Malaysian Airline Crash In Ukraine
Auto Parts Makers Drive Higher (Fox Business)

TRW Automotive (NYSE: TRW) shares jumped Thursday on a report that a suitor may sweeten its bid by around 13 percent.

TRW confirmed a week ago that it received a preliminary bid for an undisclosed amount from a company it didn't name.

The suitor, widely reported as German auto supplier ZF Friedrichshafen AG, has reportedly just obtained financing for a bid of $13 billion, according to Bloomberg news service. Previously the bid was reported at $11 billion to $13 billion.

TRW said last week it was evaluating the bid "as well as other strategic alternatives."

Bloomberg's unnamed sources said a deal could be signed in three to four weeks and ZF will discuss the bid with employees Friday.

ZF is said to be working with Citigroup, Morgan Stanley and several European banks.

TRW traded recently at $103.65, up 2.42 percent.

Posted-In: ZF Friedrichshafen AGNews Rumors M&A





UPDATE: Lockheed Martin Posts Upbeat Q2 Earnings, Lifts 2014 Forecast

Courtesy of Benzinga.

Related LMT
Defense Stock Roundup: Textron Reports Impressive Q2 Earnings, Lockheed Wins Indian Super Hercules Contract
Lockheed Martin Beats on Q2 Earnings and Sales, Boosts View
Lockheed Martin to Freeze Pension Program (Fox Business)

Lockheed Martin (NYSE: LMT) reported a 3.5% gain in its second-quarter profit and lifted its 2014 earnings forecast.

Lockheed Martin’s quarterly profit surged to $889 million, versus a year-ago profit of $859 million. Its earnings per share rose to $2.76 from $2.64. The recent quarter net earnings included FAS/CAS pension income of $85 million, which raised net earnings by $0.16 per share. However, the year-ago quarter also included FAS/CAS pension expense of $120 million, which lowered net earnings by $0.23 per share.

Its sales fell 1% to $11.31 billion from $11.4 billion in the period. However, analysts were expecting earnings of $2.66 per share on revenue of $11.14 billion.

Aeronautics’ net sales rose 13% y/y, while Information Systems & Global Solutions net sales fell 8%. Missiles and Fire Control net sales dropped 7%, while Mission Systems and Training net sales were comparable to the year-ago period. Space Systems’ net sales slipped 11% y/y.

Cash from operations rose to $977 million, from $623 million in the year-ago quarter.

Lockheed Martin still projects 2014 sales to be flat versus last year. However, it now expects 2014 earnings of $10.85 to $11.15 per share, versus $10.50 to $10.80 per share.

Lockheed Martin Chairman, President and CEO Marillyn Hewson said, “Based on our solid program execution and operational performance through the first half of the year, we increased our 2014 financial guidance for profit, earnings, and cash flow.”

Lockheed Martin shares gained 2.47% to $167.00 in pre-market trading.

Posted-In: profitEarnings News Guidance





UPDATE: PepsiCo Posts Upbeat Q2 Earnings, Shares Rise

Courtesy of Benzinga.

Related PEP
#PreMarket Primer: Wednesday, July 23: Documents Show Deutsche Bank Knew Of Reporting Problems
Earnings Scheduled For July 23, 2014
Know Before the Bell: Car Hackers and Frito-Lay's Flavor Contest (Fox Business)

Shares of PepsiCo (NYSE: PEP) gained more than 2% in pre-market trading after the company reported better-than-expected second-quarter results and raised its full-year earnings outlook.

The Purchase, New York-based company posted a quarterly profit of $1.978 billion, or $1.29 per share, versus a year-ago profit of $2.010 billion, or $1.28 per share. Its adjusted earnings came in at $1.32 per share.

Its revenue gained 0.5% to $16.894 billion, while organic revenue rose 3.6%. However, analysts were expecting earnings of $1.23 per share on revenue of $16.8 billion.

PepsiCo’s net revenue climbed 2% for global snacks, and fell 1% for global beverages. Its developing and emerging market net revenue slipped 1% in the quarter.

Net revenue in the PepsiCo Americas Foods division rose 1%, while revenue in Frito-Lay North America climbed 2% in the quarter. Latin America Foods net revenue was even compared to the year-ago quarter.

PepsiCo’s carbonated soft drink volumes slipped 2% in North America, while non-carbonated beverage volume gained 1%.
Chairman and CEO Indra Nooyi said, “Despite operating in what continues to be a challenging and volatile macro environment, we are delivering consistent, strong results.”

Nooyi added, “Based on the strength of our year-to-date results and our outlook for the remainder of the year, we’re increasing our full-year, core constant currency EPS growth target to eight percent.” PepsiCo earlier expected FY14 core constant currency EPS growth of 7%.

It now projects organic revenue to grow mid-single digits compared to 2013. PepsiCo is targeting over $10 billion in cash flow in 2014.

PepsiCo’s shares gained 2.15% to $91.09 in pre-market trading.

Posted-In: profitEarnings News Guidance





UPDATE: MLV & Co. Upgrades Starwood Hotels & Resorts Worldwide

Courtesy of Benzinga.

Related HOT
UPDATE: Morgan Stanley Reiterates On Starwood Hotels & Resorts Worldwide On Potential Value Creation
Benzinga's Top Upgrades
Starwood Hotels Re-enters Bolivia After 30 Years (Fox Business)

In a note released Thursday morning, the team at MLV upgraded shares of Starwood Hotels & Resorts Worldwide (NYSE: HOT) from Hold to Buy and raised the price target from $86 to $96.

The team wrote, "Our upgrade is based on our view that an improving economic landscape in the Eurozone will translate into increased asset sales and share repurchases, exceeding current muted expectations."

The team added that due to the relative underperformance of the stock, "now is the time to enter."

Highlights from the note:

  • Economists forecasting accelerated economic growth in Europe through 2014. Starwood has more European exposure than most peers.
  • Believe the majority of Starwood's properties which are potentially for sale are in Europe and Latin America, where the buyer pool is beginning to expand.
  • Expected asset sales raised by $100 million in 2014 and $400 million in 2015. Total combined expected asset sales for 2014 and 2015 ~$1.5 billion.
  • Expect over $1.5 billion of share repurchases over the next seven quarters.

Posted-In: MLVAnalyst Color News Upgrades Price Target Buybacks Analyst Ratings





CA Technologies Seeks Injunction Against AppDynamics’ Use Of CA Intellectual Property

Courtesy of Benzinga.

Related CA
Top 4 NASDAQ Stocks In The Business Software & Services Industry With The Highest Revenue
Top 4 Stocks In The Business Software & Services Industry With The Highest Revenue

CA Technologies (NASDAQ: CA) today announced it has filed counterclaims against AppDynamics, Inc. and its founders, Jyoti Bansal (“Bansal”) and Bhaskar Sunkara (“Sunkara”), in a lawsuit pending in the U.S. District Court for the Northern District of California. It is clear that significant portions of the AppDynamics code was written while its founders were CA employees. CA will take every necessary step to ensure that others do not use its code or infringe its patents.

CA is seeking a court declaration that it owns the code written prior to Bansal’s and Sunkara’s departure from CA as well as any derivative works. CA is also seeking an injunction against AppDynamics prohibiting the misuse of CA’s intellectual property and financial damages.

The claims filed today allege that Bansal and Sunkara secretly began to develop an Application Performance Monitoring (APM) product and business to compete directly with CA while they were still CA employees. CA maintains that these actions occurred after CA acquired Wily Technologies, its APM product and its key software engineers in 2006. CA alleges these actions violated obligations Bansal and Sunkara had under agreements with CA, breached duties they owed under law and infringed CA’s intellectual property rights.

In April 2013, CA filed a patent infringement suit against AppDynamics, Inc. in the U.S. District Court for the Eastern District of New York. CA discovered the facts underlying its current claims during pre-trial proceedings in the New York case.

Posted-In: News Legal Press Releases





Benzinga’s M&A Chatter for Tuesday July 22, 2014

Courtesy of Benzinga.

The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday July 22, 2014:

CIT Group to Acquire OneWest Bank for $3.4B in Cash, Stock

The Deal:
CIT Group (NYSE: CIT) announced Tuesday, that it has entered into a definitive agreement and plan of merger with the parent company of privately-held OneWest Bank for $3.4 billion in cash and stock. Under the terms of the agreement, Shareholders of OneWest’s parent company, IMB Holdco, will receive $2 billion in cash and 31.3 million shares of CIT Group common stock.

The deal has been approved by both company’s Boards of Directors.

CIT Group closed Tuesday at $48.71, a gain of almost 11%.

LinkedIn Announces Purchase of Bizo, Valued at $175M

The Deal:
LinkedIn (NYSE: LNKD) announced Tuesday, that it has agreed to acquire Bizo, in a deal valued at approximately $175 million, cosnisiting of approximately 10 percent stock and approximately 90 percent cash. The deal is expected to close Q3 of 2014.

LinkedIn closed Tuesday at $165.50, a gain of 2%.

Report Respsol May Explore Talisman Energy Bid

The Rumor:
Shares of Talisman Energy (NYSE: TLM) spiked higher after-hours Tuesday, on a report from Bloomberg that Spain’s Repsol (OTC: REPYY) may explore a bid for the Canadian oil and gas company. Repsol is reportedly looking for a place to put its cash, following the loss of its stake in YPF (NYSE: YPF), according to sources.

Talisman shares closed Tuesday at $9.85, and gained 11% after-hours.

Report PetSmart Hires JPMorgan to Explore Potential Deal

The Rumor:
PetSmart (NASDAQ: PETM) has reportedly hired JPMorgan Chase to consider strategic alternatives, including a potential sale, according to a report Tuesday from Reuters. Two of PetSmart’s largest shareholders, Jana Partners and Longview Asset Management, with a combined 20% stake, have urged PetSmart to consider a sale. Dow Jones reported on July 17 that PetSmart was interviewing investment banks.

PetSmart closed Tuesday at $69.34, a gain of $.18.

Posted-In: News Rumors M&A Movers





Microsoft Misses FQ4 Bottom Line On 17% Revenue Growth

Courtesy of Benzinga.

Related MSFT
Unwired Release Confirms Suit Against Microsoft Related to Breach of Contract for Sept. 11th Licensing Deal
Earnings Season Boosts Confidence; S&P Trades At Record Highs
Microsoft 4Q EPS Misses Street View (Fox Business)

Microsoft (NASDAQ: MSFT) missed earnings expectations, but posted a 17 percent increase in fiscal fourth-quarter revenue, citing strong results from its cloud-based products.

Profits fell seven percent to $4.61 billion, or $0.56 per share, from $4.97 billion, or $0.59 a year earlier. Revenue grew to $23.38 billion, from $19.896 a year earlier.

Wall Street expected $0.60 per share on revenue of $23 billion.

Gross margin widened to $15.78 billion, from $14.29 billion a year earlier.

"I'm proud our aggressive move to the cloud is paying off," Chief Executive Satya Nadella said in a statement, noting that cloud revenue doubled to a $4.4 billion annual run rate.

Revenue for cloud-based Office 365 and Azure both grew more than 100 percent, according to Chief Operating Officer Kevin Turner.

The $7 billion acquisition of Nokia completed in April contributed earnings in the fourth quarter of $0.08 per share along with $1.99 billion in revenue, the company said.

An outlook for fiscal 2015 earnings is expected in a conference call starting at 5:30 p.m. ET.

Microsoft traded recently after-hours at $45.15, up 0.71 percent.

Posted-In: Nokia Satya NadellaEarnings News Guidance After-Hours Center





 

Help One Of Our Own PSW Members

"Hello PSW Members –

This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible.  Feel free to contact me directly at jennifersurovy@yahoo.com with any questions.

Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts.  After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.)  Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.

http://www.youcaring.com/medical-fundraiser/help-get-shadowfax-out-from-the-darkness-of-medical-bills-/126743"

Thank you for you time!

 
 

Chart School

Pssst ... A Breakout in China?

Courtesy of Doug Short.

Advisor Perspectives welcomes guest contributions. The views presented here do not necessarily represent those of Advisor Perspectives.

Many major stock indexes in the United States and Europe are either at all-time highs or near them. One sixth of the world's population can't make the same statement.

The chart below illustrates that the Shanghai Index and the popular China ETF (FXI) have both greatly underperformed the S&P 500 over the past five years ... by more than 100%!


Click for a larger image

The next chart highlights that the Shanghai Index and FXI are...



more from Chart School

Zero Hedge

Caption Contest: The Lifecycle Of An ISIS Fanatic

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

From life-saver to life-taker...

 

Source: Al Arabiya

...

more from Tyler

Phil's Favorites

Ukraine Caught in Third Major Lie? Magic Number 312

Courtesy of Mish.

I have strong evidence from Ukrainian citizen Anatoly Shary that Kiev is caught in a third major lie regarding Buk deployment.

It takes a while to go over the evidence, condensed below, all having to do with the number 312 painted on a missile launcher.

Follow the Number

On March 8, Censor.Net, a Ukrainian Nationalist cite, says "Ukraine Defends Donetsk From Russian Incursion: 'Buk' Air Defense Rocket Systems Are Taking Up Positions. PHOTO + VIDEO"

The sub-headline reads: "A resident of Gorlovka, driving to work in Soledar, came across an entire convoy of military equipment. ...My coworkers and I counted 11 missile launchers ..."
...



more from Ilene

Insider Scoop

Relaxed Regulations Highlight Nuclear ETFs

Courtesy of Benzinga.

The Environmental Protection Agency is considering a review of its 1977 rule that limits the amount of whole-body radiation that any member of the public can be exposed to as a result of the uranium fuel cycle.

While they have not made any immediate determination to change the current level of 0.25 millisieverts per year of allowable radiation, they are reviewing the scientific data to decide if changes need to be made.

Items under review include water resource protection, spent fuel storage facilities and alternative technologie...



http://www.insidercow.com/ more from Insider

Option Review

Sizable Call Spread Trades On Orexigen

A large call spread initiated on Orexigen Therapeutics, Inc. (Ticker: OREX) on Monday morning looks for shares in the name to rally approximately 30% by September expiration. The September expiration is noteworthy as the company awaits the results of the FDA’s review of its resubmitted New Drug Application (NDA) for NB32, an investigational medication being evaluated for weight loss, after the review was extended for three months back in June. The upcoming Prescription Drug User Fee Act (PDUFA) date is September 11, 2014, according to a press release issued by the company. Shares in Orexigen today are up roughly 0.40% at $5.34 as of 2:15 p.m. ET.

...

more from Caitlin

All About Trends

Mid-Day Update

Reminder: David is available to chat with Members, comments are found below each post.

Click here for the full report.




To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David

Sabrient

Sector Detector: Bulls remain unfazed by borderline Black Swans

Courtesy of Sabrient Systems and Gradient Analytics

Despite a highly eventful week in the news, not much has changed from a stock market perspective. No doubt, investors have grown immune to the daily reports of geopolitical turmoil, including Ukraine vs. Russia for control of the eastern regions, Japan’s dispute with China over territorial waters, Sunni vs. Shiite for control of Iraq, Christians being driven out by Islamists, and other religious conflicts in places like Nigeria and Central African Republic. But last Thursday’s news of the Malaysian airliner tragically getting shot down over Ukraine, coupled with Israel’s ground incursion into Gaza, had the makings of a potential Black Swan event, which in my view is the only thing that could derail the relentless bull march higher in stocks.

Nevertheless, when it became clear that the airline...



more from Sabrient

OpTrader

Swing trading portfolio - week of July 21st, 2014

Reminder: OpTrader is available to chat with Members, comments are found below each post.

 

This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...



more from OpTrader

Stock World Weekly

Stock World Weekly

Newsletter writers are available to chat with Members regarding topics presented in SWW, comments are found below each post.

Here's the latest Stock World Weekly. Please use your PSW user name and password to log in. (You may take a free trial here.)

#452331232 / gettyimages.com ...

more from SWW

Market Shadows

Danger: Falling Prices

Danger: Falling Prices

By Dr. Paul Price of Market Shadows

 

We tried holding up stock prices but couldn’t get the job done. Market Shadows’ Virtual Value Portfolio dipped by 2% during the week but still holds on to a market-beating 8.45% gain YTD. There was no escaping the downdraft after a major Portuguese bank failed. Of all the triggers for a large selloff, I’d guess the Portuguese bank failure was pretty far down most people's list of "things to worry about." 

All three major indices gave up some ground with the Nasdaq composite taking the hardest hi...



more from Paul

Digital Currencies

Bitcoin Vs Gold - The Infographic

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

While Marc Faber has said "I will never sell my gold," he also noted "I like the idea of Bitcoin," and the battle between the 'alternative currencies' continues. The following infographic provides a succinct illustration of the similarities and differences between gold and bitcoin.

Please include attribution to www.jmbullion.com with this graphic.

...

more from Bitcoin

Pharmboy

Biotechs & Bubbles

Reminder: Pharmboy is available to chat with Members, comments are found below each post.

Well PSW Subscribers....I am still here, barely.  From my last post a few months ago to now, nothing has changed much, but there are a few bargins out there that as investors, should be put on the watch list (again) and if so desired....buy a small amount.

First, the media is on a tear against biotechs/pharma, ripping companies for their drug prices.  Gilead's HepC drug, Sovaldi, is priced at $84K for the 12-week treatment.  Pundits were screaming bloody murder that it was a total rip off, but when one investigates the other drugs out there, and the consequences of not taking Sovaldi vs. another drug combinations, then things become clearer.  For instance, Olysio (JNJ) is about $66,000 for a 12-week treatment, but is approved for fewer types of patients AND...



more from Pharmboy

Promotions

See Live Demo Of This Google-Like Trade Algorithm

I just wanted to be sure you saw this.  There’s a ‘live’ training webinar this Thursday, March 27th at Noon or 9:00 pm ET.

If GOOGLE, the NSA, and Steve Jobs all got together in a room with the task of building a tremendously accurate trading algorithm… it wouldn’t just be any ordinary system… it’d be the greatest trading algorithm in the world.

Well, I hate to break it to you though… they never got around to building it, but my friends at Market Tamer did.

Follow this link to register for their training webinar where they’ll demonstrate the tested and proven Algorithm powered by the same technological principles that have made GOOGLE the #1 search engine on the planet!

And get this…had you done nothing b...



more from Promotions



FeedTheBull - Top Stock market and Finance Sites



About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>